KATE TAYLOR: Open Payments
NPI 1700024932 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 20 payments from 15 companies in 2025. Trend: 2023 $537 · 2024 $904 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $149 |
| Hologic Sales and Service, LLC | 2 | $134 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $119 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Novo Nordisk Inc | 1 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $91 |
| ABBVIE INC. | 3 | $55 |
Products named: LEQEMBI, REXULTI, APTIMA, GATTEX, MOUNJARO, TZIELD, AREXVY, XIFAXAN.
Industry payments across TX — which companies pay providers there.
